Reimbursement - Cosentyx PsA
Mechanism of action - Cosentyx PsA
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Twitter Linkedin Facebook Pinterest Google plusDosing - Consentyx PsA
Patient Resources - Cosentyx PsA
Reimbursement - Cosentyx PsO / HS
Convenient prescription¹ Initial reimbursement request for Cosentyx ® : 8 packs of 1x 300 mg for first 16 weeks 5 for the start-up 3 for the maintenance treatment (monthly injections)Prolongation of reimbursement...
Twitter Linkedin Facebook Pinterest Google plusCosentyx® - PSA
Efficacy - Kesimpta
Safety Profile - Kesimpta
Administration & Dosing
×